C Subathra Devi (10 results)

Condition: New. pp. 68.

Paperback. Condition: Brand New. 80 pages. 8.66x5.91x0.19 inches. In Stock.

Taschenbuch. Condition: Neu. Streptokinase-A novel clot buster | Studies on screening, strain development, production and optimization of streptokinase from -hemolytic streptococci | C.Subathra Devi (u. a.) | Taschenbuch | Englisch | LAP Lambert Academic Publishing | EAN 9783659178689 | Verantwortliche Person für die EU: LAP Lambert Academic Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu.…

Condition: New. Print on Demand pp. 68 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.

Condition: New. PRINT ON DEMAND pp. 68.

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The rapid prevalence and resistance of pathogenic bacteria have been evolving and spreading resistance to diverse classes of antibiotics. As a result, it is very difficult to control and treat infectious diseases. Understanding antibiotic resistance, therefore it is essential to identify the strains with respect to genetic exchange. Further studies focused on differentiation patterns using fingerprinting methods will provide better findings. The information gathered from these types of studies may help us manage the evolution of antimicrobial resistance patterns.…

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Naine S. JemimahMs. S. Jemimah Naine is currently working as Research associate at VIT University. Her research is inspired by naturally occurring antibiotics and antitumor compounds as well focused on molecular mechanisms involved i.…

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The leading cause of death in the world is coronary heart diseases. According to World Health Organisation (WHO) cardiovascular disease caused over 18 million deaths in the world in 2005. Of these deaths, 8 million (44%) occurred in people under 60 years of age. In the recent years, of the several thrombolytic agents used clinically, streptokinase is prone of the most-often employed, particularly of its lower cost when coded to others. This book deals with streptokinase as a clinically important and cost-effective plasminogen activator. Streptokinase is a non-proteolytic extracellular protein produced by Streptococcus species. It is the best, least expensive, efficient, highly potent plasminogen activator of fibrinolysis and routinely applied in clinical medicine for thrombolytic therapy for the treatment of diverse circulatory disorders. Presently there is about 80- 90% of demand for streptokinase. As per market research 2011 report, Asia, Europe and North America are the leading countries worldwide in manufacturing and supplying streptokinase. This book provides more information about hemolytic Streptococci and the strain improvement methods to enhance streptokinase production.…

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: V. MohanasinivasanDr.V.Mohanasrinivasan and Dr.C.Subathra Devi are currently working as Assistant Professor senior at VIT University, Vellore, Tamil Nadu, India. Both of them are expertise in industrial enzymes and proteins.Currently.…

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: C. Subathra DeviDr.C.Subathra Devi and Dr.V.Mohanasrinivasan are currently working as Assistant Professor Senior at VIT University, Vellore, Tamil Nadu, India. Both of them are expertise in industrial enzymes especially on clot buste.…